Primary aldosteronism with normal plasma aldosterone was associated with a lower risk of cardiovascular and cerebrovascular events compared to high aldosterone (OR 0.42; 95% CI 0.18-0.90; P<0.05).
Cross-Sectional (n=790)
Does primary aldosteronism with normal plasma aldosterone concentration carry a different risk of cardiovascular and cerebrovascular events compared to high PAC primary aldosteronism or essential hypertension?
Primary aldosteronism patients with normal plasma aldosterone levels have a lower risk of cardiovascular and cerebrovascular events compared to those with high levels, with a risk profile similar to essential hypertension.
Effect estimate: OR 0.42 (95% CI 0.18-0.90)
p-value: p=<0.05
BACKGROUND: Previous studies showed higher risk of cardiovascular and cerebrovascular (CCV) events in primary aldosteronism compared with essential hypertension, but the patients of these studies were limited to primary aldosteronism patients with high plasma aldosterone concentration (PAC). The introduction of the aldosterone-renin ratio as the screening test for primary aldosteronism led to the recognition of primary aldosteronism patients with normal PAC (nPA). However, there is no information on the risk of primary aldosteronism including nPA. METHOD: In this retrospectively and cross-sectional study, the clinical features and CCV event risk of primary aldosteronism at diagnosis including nPA were investigated and compared with essential hypertension. The study included 292 consecutive primary aldosteronism patients and 498 essential hypertension outpatients. All primary aldosteronism patients were diagnosed by autonomous aldosterone secretion using confirmatory tests, and then divided into nPA (n = 130) and primary aldosteronism patients with high PAC (hPA: n = 162) using a PAC cutoff level of less than 443 pmol/l (16 ng/dl), representing the normal upper limit of PAC. RESULTS: nPA patients were significantly older at diagnosis of primary aldosteronism and at onset of hypertension compared with hPA patients. They had milder hypokalemia and easier-to-control blood pressure. The results suggested that nPA could be considered a mild type of primary aldosteronism but not an early-stage hPA. Moreover, the risk of all CCV events in nPA was significantly lower than that in hPA (odds ratio 0.42, 95% confidence interval 0.18-0.90, P < 0.05) and not significantly higher than that in essential hypertension (odds ratio 0.95, 95% confidence interval 0.43-1.94, P = 0.899). CONCLUSION: This study suggests that aggressive diagnostic workout for nPA is less effective to prevent CCV events.
Murata et al. (Wed,) conducted a cross-sectional in Primary aldosteronism and essential hypertension (n=790). Normal plasma aldosterone concentration (nPA) vs. High plasma aldosterone concentration (hPA) and essential hypertension was evaluated on Cardiovascular and cerebrovascular (CCV) events (OR 0.42, 95% CI 0.18-0.90, p=<0.05). Primary aldosteronism with normal plasma aldosterone was associated with a lower risk of cardiovascular and cerebrovascular events compared to high aldosterone (OR 0.42; 95% CI 0.18-0.90; P<0.05).